Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
- PMID: 15263907
- DOI: 10.1038/sj.mp.4001558
Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence
Erratum in
- Mol Psychiatry. 2005 Apr;10(4):420
- Mol Psychiatry. 2005 Aug;10(8):804
Abstract
This review critically summarizes the neuropathology and genetics of schizophrenia, the relationship between them, and speculates on their functional convergence. The morphological correlates of schizophrenia are subtle, and range from a slight reduction in brain size to localized alterations in the morphology and molecular composition of specific neuronal, synaptic, and glial populations in the hippocampus, dorsolateral prefrontal cortex, and dorsal thalamus. These findings have fostered the view of schizophrenia as a disorder of connectivity and of the synapse. Although attractive, such concepts are vague, and differentiating primary events from epiphenomena has been difficult. A way forward is provided by the recent identification of several putative susceptibility genes (including neuregulin, dysbindin, COMT, DISC1, RGS4, GRM3, and G72). We discuss the evidence for these and other genes, along with what is known of their expression profiles and biological roles in brain and how these may be altered in schizophrenia. The evidence for several of the genes is now strong. However, for none, with the likely exception of COMT, has a causative allele or the mechanism by which it predisposes to schizophrenia been identified. Nevertheless, we speculate that the genes may all converge functionally upon schizophrenia risk via an influence upon synaptic plasticity and the development and stabilization of cortical microcircuitry. NMDA receptor-mediated glutamate transmission may be especially implicated, though there are also direct and indirect links to dopamine and GABA signalling. Hence, there is a correspondence between the putative roles of the genes at the molecular and synaptic levels and the existing understanding of the disorder at the neural systems level. Characterization of a core molecular pathway and a 'genetic cytoarchitecture' would be a profound advance in understanding schizophrenia, and may have equally significant therapeutic implications.
Comment in
-
New directions in psychiatric therapeutics.NeuroRx. 2006 Jan;3(1):1-2. doi: 10.1016/j.nurx.2005.12.011. NeuroRx. 2006. PMID: 16490408 Free PMC article. No abstract available.
Similar articles
-
Genetic mechanisms of psychosis: in vivo and postmortem genomics.Clin Ther. 2005;27 Suppl A:S8-15. doi: 10.1016/j.clinthera.2005.07.016. Clin Ther. 2005. PMID: 16198200 Review.
-
[Gene polymorphism and gene expression in schizophrenia].Psychiatr Hung. 2006;21(6):404-12. Psychiatr Hung. 2006. PMID: 17438657 Review. Hungarian.
-
Schizophrenia: genes at last?Trends Genet. 2005 Sep;21(9):518-25. doi: 10.1016/j.tig.2005.06.011. Trends Genet. 2005. PMID: 16009449 Review.
-
Susceptibility genes for schizophrenia: characterisation of mutant mouse models at the level of phenotypic behaviour.Neurosci Biobehav Rev. 2007;31(1):60-78. doi: 10.1016/j.neubiorev.2006.04.002. Epub 2006 Jun 19. Neurosci Biobehav Rev. 2007. PMID: 16782199 Review.
-
The association between the Val158Met polymorphism of the catechol-O-methyl transferase gene and morphological abnormalities of the brain in chronic schizophrenia.Brain. 2006 Feb;129(Pt 2):399-410. doi: 10.1093/brain/awh702. Epub 2005 Dec 5. Brain. 2006. PMID: 16330500
Cited by
-
Genetic Influences on Cognitive Dysfunction in Schizophrenia.Curr Top Behav Neurosci. 2023;63:291-314. doi: 10.1007/7854_2022_388. Curr Top Behav Neurosci. 2023. PMID: 36029459
-
Synaptic underpinnings of altered hippocampal function in glutaminase-deficient mice during maturation.Hippocampus. 2012 May;22(5):1027-39. doi: 10.1002/hipo.22014. Epub 2012 Mar 19. Hippocampus. 2012. PMID: 22431402 Free PMC article.
-
[One decade of functional imaging in schizophrenia research. From visualisation of basic information processing steps to molecular-genetic oriented imaging].Radiologe. 2005 Feb;45(2):113-8, 120-3. doi: 10.1007/s00117-004-1154-1. Radiologe. 2005. PMID: 15742098 Review. German.
-
Imaging genomics and response to treatment with antipsychotics in schizophrenia.NeuroRx. 2006 Jan;3(1):117-30. doi: 10.1016/j.nurx.2005.12.001. NeuroRx. 2006. PMID: 16490418 Free PMC article. Review.
-
De novo mutations in the gene encoding the synaptic scaffolding protein SHANK3 in patients ascertained for schizophrenia.Proc Natl Acad Sci U S A. 2010 Apr 27;107(17):7863-8. doi: 10.1073/pnas.0906232107. Epub 2010 Apr 12. Proc Natl Acad Sci U S A. 2010. PMID: 20385823 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous